Bonpoze Combikit

Bonpoze Combikit is a scientifically designed two-part combination therapy formulated to address the full spectrum of climacteric (menopausal and peri-menopausal) health challenges. It delivers a Liquid Filled Capsule containing Soya Isoflavonoids and Evening Primrose Oil, paired with a Tablet containing Tribasic Calcium Phosphate, Vitamin D3, and Vitamin K2 — together providing a holistic, hormone-free approach to menopause management.

Climacteric is not just about hot flashes. It is accompanied by accelerated bone loss, cardiovascular risk elevation, cognitive decline, mood disturbances, and sleep disruption — all occurring simultaneously. Bonpoze Combikit is designed to address all of these consequences in a single, convenient, and safe daily regimen.

The Two-Part Kit — What Each Component Does

Capsule: Soya Isoflavonoids 100 mg + Evening Primrose Oil 300 mg (Liquid Filled)

Soya Isoflavonoids:

• Mimic estrogen actions selectively and safely — providing phytoestrogenic activity without the risks of synthetic hormone therapy
• Effectively treat hot flashes, night sweats, troubled sleep, fatigue, and mood swings
• Preserve bone mass via interaction with estrogen receptors in bone tissue
• Improve lipid profile and reduce serum cholesterol
• Reduce the risk of dementia through neuroprotective phytoestrogenic activity

Evening Primrose Oil:

• Provides essential fatty acids (GLA — Gamma Linolenic Acid) that support hormonal balance
• Helps normalize body functions and alleviate menopausal symptoms including hot flashes and skin dryness
• Anti-inflammatory properties support joint and cardiovascular health during menopause

Tablet: Tribasic Calcium Phosphate 1.032 g + Vitamin D3 400 IU + Vitamin K2 7.45 MCG

Tribasic Calcium Phosphate:

• Ensures calcium supply, absorption, and deposition in bone tissue
• Directly counters the accelerated bone loss associated with estrogen withdrawal during menopause

Vitamin D3:

• Enhances intestinal calcium absorption
• Essential co-factor for effective bone mineralization

Vitamin K2 (MK-7):

• Activates osteocalcin — directing calcium into bones rather than soft tissues
• Prevents arterial calcification — a significant cardiovascular risk in post-menopausal women
• Prevents menopause-induced impairment of brain function
• Reduces the risk of dementia in combination with Soya Isoflavonoids

Addressing the Three Core Climacteric Challenges

1. Treats Menopausal Symptoms
Bonpoze’s Soya Isoflavonoids + Evening Primrose Oil combination normalizes body functions and effectively treats hot flashes, night sweats, troubled sleep, fatigue, and mood swings — without the adverse effects associated with conventional hormone replacement therapy.

2. Prevents Postmenopausal Osteoporosis
The calcium-vitamin D3-K2 combination ensures bone mass is preserved by supplying adequate calcium, enhancing its absorption through D3, and directing it into bone tissue through K2’s activation of osteocalcin. Soya Isoflavonoids further preserve bone mass via estrogen receptor interaction in bone.

3. Checks CVD Risk and Cognitive Decline
Post-menopausal cardiovascular risk is addressed through improved lipid profiles (Soya Isoflavonoids), prevention of arterial calcification (Vitamin K2), and dementia risk reduction — making Bonpoze a genuinely comprehensive climacteric care solution.

Why Bonpoze Over Hormone Replacement Therapy

• Free from HRT risks — no increased risk of breast cancer, blood clots, or stroke
• No undesired hormonal side effects
• Safe for long-term use as a preventive and maintenance therapy
• Recommended as a safe alternative to hormone therapy by leading gynaecological societies
• Combines symptom management with disease prevention in a single kit

Clinical Indications

• Peri-menopausal and post-menopausal symptom management
• Prevention of postmenopausal osteoporosis
• Cardiovascular risk reduction in post-menopausal women
• Cognitive support and dementia risk reduction
• Patients seeking a hormone-free alternative to HRT
• Women with contraindications to conventional hormone replacement therapy

Composition